Fundraising by IPO and the future of bioprinting

Overview

Industrious Boston Seaport
22 Boston Wharf Rd
Boston, MA
United States

Tuesday, 19 March 2019 - 6:00pm

View Event Page

Details

CELLINK is the first bioink company in the world that focuses on the development and commercialization of bioprinting technologies that allow researchers to 3D print human organs and tissues for the development of pharmaceutical and cosmetic treatments. CELLINK’s innovative and patent pending bioink is a biomaterial innovation that enables human cells to grow and thrive such as they would in the natural human body environment. This is an ideal material for tissue engineering and life science applications.

Today, the company’s disruptive technology platform is being utilized to print tissues such as cartilage, skin, and even fully functional cancer tumors that can then be used to develop new cancer treatments. The company has, within 12 months, been able to commercialize products in approximately 50+ countries and sold to over 600 of prestigious labs around the world, such as Harvard, MIT, the FDA and several others.

The company has managed to turn profitable within only 3 months of operations. CELLINK’s largest market today is North America, followed by Europe, and Asia.

The company was started on the 27th of January, 2016 in Gothenburg, Sweden by Erik Gatenholm and Hector Martinez. The focus was to change the world of medicine by disrupting the entire medical research industry. On the 3rd of November (only 10 months after starting), CELLINK made an IPO on the NASDAQ stock exchange in Stockholm to raise funding.

CELLINK has offices in Gothenburg, Sweden, Cambridge, MA, Blacksburg, VA and Kyoto, Japan.

Notable Awards:

  • Forbes 30 under 30 (Erik Gatenholm) 2018
  • Red Dot Award 2018
  • Sweden’s Pioneer Award - Hector Martinez 2018
  • Business Insider’s List of Sweden’s Top Tech Stars List (Erik Gatenholm and Hector Martinez) 2018
  • Nordic Startup Award Best Healthcare/Lifestyle Startup Sweden 2017
  • Nordic Startup Award Best Healthcare/Lifestyle Startup in the Nordics 2017
  • Anders Wall Exceptional Entrepreneurship Award 2017
  • Arvid Carlsson Award 2017
  • Winner "Swedish Exponential Startup of the Year" 2016 - Nordic startup awards
  • Winner "Diamond of the Year Award" 2016 – Fourier Transform
  • Winner "Innovator of the Year 2016" (Erik Gatenholm) - Universum and Danske Bank
  • Winner "Young Entrepreneur of the Year (west Sweden) (Erik Gatenholm)" – Founders Alliance
  • Startup of the Year 2016 - Almedalen (This would give CELLINK the title of “Swedish Startup of the Year” as this is the most prestigious business event in Sweden)
  • Business Insider’s List of Sweden’s Top Tech Stars List (Erik Gatenholm and Hector Martinez)
  • Nordic Startup Award Best Healthcare/Lifestyle Startup Sweden 2017
  • Nordic Startup Award Best Healthcare/Lifestyle Startup in the Nordics 2017
  • Anders Wall Exceptional Entrepreneurship Award 2017
  • Arvid Carlsson Award 2017

 

CELLINK 2018 Highlights:

Net turnover of SEK 45,337 thousand (SEK 13,159 thousand), an increase of 245% against the previous accounting year

Operating revenues, including capitalized work for own account and changes in inventory, amounted to SEK 64,444 thousand (SEK 21,876 thousand), an increase of 196% against the previous accounting year

  • On 8 January the company announced a collaboration agreement with CTIBIOTECH to print human cancer tumor tissues
  • On 17 January the company announced its establishment of a research and development laboratory in AstraZeneca’s BioVentureHub
  • On 1 February CELLINK advised it would be opening an office at Kyoto University in Japan
  • On 8 February CELLINK advised it would be launching CELLINK X Bioinks
  •